Di Zhong
23 You Zheng Street
Harbin, 150001, China
Harbin, 150001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Retraction notice to "The effect of vitamin C on the JAK/STAT3 pathway in ischemic stroke: Based on the molecular interaction between FOXP3 protein and stat3 protein" [Int. J. Biol. Macromol. 311 (2025) 144069].
Journal: International journal of biological macromolecules
Published: August 04, 2026
A phase III clinical trial of PXT3003 in Chinese patients with Charcot-Marie-Tooth disease type 1A.
Journal: iScience
Published: April 15, 2026
Dyslipidemia is associated with monocyte lipid metabolic reprogramming in Guillain-Barré syndrome.
Journal: Frontiers in neurology
Published: January 27, 2026
The EGR1/ZFP36 axis governs glycosphingolipid metabolic reprogramming in monocyte-derived macrophages in guillain-barré syndrome.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: January 19, 2026
Peripheral blood T-cell subsets combined with EGRIS score predict the need for mechanical ventilation in Guillain-Barré syndrome.
Journal: Frontiers in immunology
Published: November 16, 2025
The effect of vitamin C on the JAK/STAT3 pathway in ischemic stroke: based on the molecular interaction between FOXP3 protein and stat3 protein.
Journal: International journal of biological macromolecules
Published: March 05, 2025
Ubiquitination of ALOX15 regulates endoplasmic reticulum stress in Schwann cells and experimental autoimmune neuritis (EAN) models.
Journal: Free radical biology & medicine
Published: March 03, 2025
Using Olink Proteomics to Identify Inflammatory Biomarkers in the Cerebrospinal Fluid in Guillain-Barré Syndrome.
Journal: Journal of inflammation research
Published: December 05, 2024
Disulfiram downregulates ferredoxin 1 to maintain copper homeostasis and inhibit inflammation in cerebral ischemia/reperfusion injury.
Journal: Scientific reports
Published: March 09, 2024
Disulfiram attenuates cell and tissue damage and blood‒brain barrier dysfunction after intracranial haemorrhage by inhibiting the classical pyroptosis pathway.
Journal: Scientific reports
Published: January 24, 2024
MyD88 Inhibition Attenuates Cerebral Ischemia-reperfusion Injury by Regulating the Inflammatory Response and Reducing Blood-brain Barrier Damage.
Journal: Neuroscience
Published: December 30, 2023
Last Updated: 09/26/2026